Healthcare Dec 28, 2020 03:13 PM (GMT+8) · EqualOcean
On December 28, the phase I project of Guangzhou Pharmaceutical production base (hereinafter referred to as "Guangzhou base") was completed in Zhongxin Guangzhou Knowledge City. It is reported that the Guangzhou base covers an area of 83000 square meters, and the project is divided into three phases. Phase I project includes preparation process development and drug production, as well as related support facilities and office facilities. The annual drug production capacity of phase I project can reach 100 million scale, which can meet the R & D and production needs of ncjh in the next 10 years. Nuocheng Jianhua is a biomedical high-tech company, focusing on the research and development of a class of new drugs in the treatment of malignant tumors and autoimmune diseases. It is suitable for lymphoma, liver cancer, cholangiocarcinoma, urothelial cancer and other malignant tumors and autoimmune diseases with high incidence in Chinese patients. At present, many new drug products are in the stage of clinical and preclinical research and development.